<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02892643</url>
  </required_header>
  <id_info>
    <org_study_id>B-1609-361-001</org_study_id>
    <nct_id>NCT02892643</nct_id>
  </id_info>
  <brief_title>Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy</brief_title>
  <official_title>Multicenter Prospective Randomized Controlled Trial of Comparing Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy for Upper Third Early Gastric Cancer (KLASS-05)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Experimental: Laparoscopic proximal gastrectomy Laparoscopy proximal gastrectomy with&#xD;
      esophago-jejunostomy, gastro-jejunostomy and jejuno-jejunostomy (double tract&#xD;
      reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should&#xD;
      be negative for malignancy with intraoperative frozen biopsy.&#xD;
&#xD;
      Active Comparator: Laparoscopic total gastrectomy Laparoscopic total gastrectomy with&#xD;
      esophago-jejunostomy and jejuno-jejunostomy (Roux-en-Y reconstruction). Systemic en bloc&#xD;
      lymph node dissection is mandatory. Resection margin should be negative for malignancy with&#xD;
      intraoperative frozen biopsy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participating Surgeons Prior to this clinical trial, only the surgeons who are considered to&#xD;
      have the standardization by review committee participated.&#xD;
&#xD;
      Patients Registration It is required to ensure that the patients meet the inclusion criteria&#xD;
      for this clinical trial, are free from any items of exclusion criteria, are explained about&#xD;
      the participation in the clinical trial along with the informed consent forms.&#xD;
&#xD;
      After rechecking the patients with the registration check list by accessing the web-based&#xD;
      randomized program provided from Seoul National University Bundang Hospital Medical Research&#xD;
      Collaborating Center.&#xD;
&#xD;
      Each group 69 patients, total 138 subjects will be enrolled. Randomization The registration&#xD;
      randomization should be done with 1:1 ratio for each researcher.&#xD;
&#xD;
      Baseline number (BN) should be provided to the subjects in the order of acquisition of&#xD;
      informed consent form. Based on the subjects who are selected as the appropriate subjects in&#xD;
      the end, the allocation number (AN) shall be provided in the order of randomized allocation&#xD;
      table.&#xD;
&#xD;
      Procedure Operations are performed according to the allocated group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 27, 2016</start_date>
  <completion_date type="Actual">September 17, 2020</completion_date>
  <primary_completion_date type="Actual">September 17, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Hemoglobin</measure>
    <time_frame>up to 2 years postoperatively</time_frame>
    <description>from blood sample</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin B12 cumulative supplement quantity</measure>
    <time_frame>up to 2 years postoperatively</time_frame>
    <description>from blood sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative morbidity</measure>
    <time_frame>30 days for early morbidity</time_frame>
    <description>Complications occuring after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative mortality</measure>
    <time_frame>mortality for 90 days</time_frame>
    <description>Mortality after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL measurement</measure>
    <time_frame>6 month, 1 year, 2 year, postoperatively</time_frame>
    <description>EORTC C30/STO22</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reflux esophagitis</measure>
    <time_frame>check at every 12 months up to 2 years postoperatively</time_frame>
    <description>assessed by Visick score and endoscopic grading according to LA classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free survival</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Relapse-free survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>2 years postoperatively</time_frame>
    <description>Overall survival</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">138</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Laparoscopic proximal gastrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopy proximal gastrectomy with esophago-jejunostomy, gastro-jejunostomy and jejuno-jejunostomy (double tract reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic total gastrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic total gastrectomy with esophago-jejunostomy and jejuno-jejunostomy (Roux-en-Y reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic proximal gastrectomy</intervention_name>
    <description>Laparoscopy proximal gastrectomy with esophago-jejunostomy, gastro-jejunostomy and jejuno-jejunostomy (double tract reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.</description>
    <arm_group_label>Laparoscopic proximal gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic total gastrectomy</intervention_name>
    <description>Laparoscopic total gastrectomy with esophago-jejunostomy and jejuno-jejunostomy (Roux-en-Y reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.</description>
    <arm_group_label>Laparoscopic total gastrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients are included in the trial if they meet all of the following criteria:&#xD;
&#xD;
        Histologically proven adenocarcinoma through endoscopic biopsy Aged 20-80 years old Written&#xD;
        signed informed consent No other malignancies Proximal gastric cancer met by following&#xD;
        conditions ; Lesion located on proximal stomach (upper one third) Lesion below 5cm in size&#xD;
        Lesion confined to mucosa or submucosa (cT1) No evidence of metastatic enlarged LN on #5,&#xD;
        6, 4d, 10 basins and other distant metastasis.&#xD;
&#xD;
        Performance status (PS) of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale&#xD;
        Performance status (PS) of I to III on American Society of Anesthesiologists (ASA) score&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients are excluded if they meet any of the following criteria:&#xD;
&#xD;
        History of anemia Patients who need total gastrectomy History of pre-operative chemotherapy&#xD;
        or radiation therapy for gastric cancer Patients who need combined resection (except&#xD;
        cholecystectomy) Presence of other malignancies Prior treatment against systemic&#xD;
        inflammatory disease Previous gastric surgery Vulnerable patients (lack of decision-making&#xD;
        capacity, pregnant, or breast-feeding women)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Soonchunhyang University Bucheon Hospital</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dankook University Hospital</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keimyung University Hospital</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eulji University Hospital, Deajon</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Hwasun</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Ilsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ewha Womans University Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeouido St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yonsei University Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 2, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>January 4, 2021</last_update_submitted>
  <last_update_submitted_qc>January 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Do Joong Park</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

